Legal & General continues its support for Venture Capital
Legal & General Capital (LGC), the principal investment arm of Legal & General Group, has completed its seventh Venture Capital platform deal with its investment in Oxford Sciences Innovation (OSI), a commercialisation platform, dedicated to breakthrough science and technology. Formed out of Oxford University, OSI has successfully raised £580 million from leading global investors to help fund the next generation of world-class technology businesses. It is the preferred partner of the University for the funding and development of companies formed from its Mathematical, Physical, Life Sciences and Medical Sciences divisions.
With the UK’s SME equity funding gap estimated at over £4 billion per annum, Legal & General sees a huge opportunity in using its patient capital to accelerate growth companies, helping to drive forward and develop the UK’s venture ecosystem and stimulate much needed economic growth. The investments offer attractive risk adjusted returns for L&G shareholders in a diversifying asset class, whilst providing investment opportunities for the Group.